Organogenesis Holdings (ORGO) Debt to Equity (2017 - 2024)

Organogenesis Holdings' Debt to Equity history runs 8 years deep, the most recent figure standing at $0.22 for Q3 2024.

• In Q3 2024, Debt to Equity fell 8.67% year-over-year to $0.22; the TTM figure through Sep 2024 stood at $0.22 (down 8.67% YoY), while the FY2023 annual figure was $0.24, down 10.78% from the prior year.
• Debt to Equity was $0.22 for Q3 2024 at Organogenesis Holdings, down from $0.24 in the prior quarter.
• In the past five years, Debt to Equity ranged from a high of $1.45 in Q2 2020 to a low of $0.01 in Q3 2021.
• Historically, Debt to Equity has averaged $0.35 across 5 years, with a median of $0.26 in 2023.
• The sharpest annual moves came in 2021 and 2022: Debt to Equity tumbled 98.81% in 2021, then surged 2351.18% in 2022.
• A 5-year view of Debt to Equity shows it stood at $0.19 in 2020, then soared by 61.8% to $0.3 in 2021, then decreased by 12.45% to $0.27 in 2022, then dropped by 10.78% to $0.24 in 2023, then dropped by 6.17% to $0.22 in 2024.
• The last three Debt to Equity figures came in at $0.22 (Q3 2024), $0.24 (Q2 2024), and $0.23 (Q1 2024), per Business Quant data.